Position in BMY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,830,179
-$318,526 QoQ
Shares Held
49,118
-5.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#711
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. BMY ranks #7 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,392 | $7,666,757 | |
| 2 | AMGN |
Amgen Inc
|
15,803 | $5,722,582 | |
| 3 | JNJ |
Johnson & Johnson
|
19,135 | $4,859,715 | |
| 4 | ABBV |
AbbVie Inc.
|
16,399 | $4,126,644 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,697 | $4,073,064 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,095 | $3,802,202 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
49,118 | $2,830,179 | |
| 8 | PFE |
Pfizer Inc
|
52,773 | $1,270,773 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,830,179 | 49,118 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,148,705 | 51,916 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,643,221 | 49,003 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,144,640 | 47,553 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,367,826 | 51,152 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,124,578 | 51,231 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,802,887 | 49,556 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,581,826 | 49,900 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,129,658 | 51,280 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,662,204 | 49,091 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,566,680 | 50,023 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,505,006 | 43,160 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,760,273 | 43,163 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,982,686 | 43,034 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,112,628 | 43,261 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,012,296 | 42,373 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $3,256,869 | 42,297 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $3,079,163 | 42,163 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,319,731 | 37,205 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,850,600 | 31,276 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,812,358 | 27,123 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,677,869 | 26,578 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,447,842 | 23,341 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $1,289,542 | 21,389 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,086,682 | 18,481 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,055,436 | 18,935 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||